Search Orphan Drug Designations and Approvals
-
Generic Name: | 5-fluoro-4-(7''-fluoro-2''-methylspiro[cyclopentane-1,3''-indol]-5''-yl)-N-(5-(1-methylpiperidin-4-yl)pyridin-2-yl)pyrimidin-2-amine fumarate |
---|---|
Date Designated: | 09/08/2020 |
Orphan Designation: | Treatment of malignant glioma |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Gan & Lee Pharmaceuticals USA Corporation 520 US Highway 22 East Suite 302 Bridgewater, New Jersey 08807 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-